Mechelen, Belgium; 8 July 2013 - Galapagos NV (Euronext: GLPG) announced today
that it has been awarded a ?2.4 million TGO (transformational medical research)
grant from the Flemish agency for Innovation by Science and Technology (IWT) for
psoriasis research and development. The goal of ...
↧